{"disease":{"id":"relapsed-refractory-locally-advanced-unresectable-melanoma-stage-iiib-iiic-or-iiid","name":"relapsed refractory locally advanced unresectable melanoma stage iiib iiic or iiid"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06984328","title":"Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1,"lead_sponsor_name":"Genmab","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}